Restenosis following percutaneous renal artery revascularization

Nephron - Clinical Practice

Volumn 107, Issue 2, 2007, Pages

  Kane, Garvan C ^a   Hambly, Niamh ^b   Textor, Stephen C ^a   Stanson, Anthony W ^a   Garovic, Vesna D ^a,c  

^a Mayo Clinic College of Medicine   (United States)

^b MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^c MAYO CLINIC   (United States)

Author keywords

Atherosclerotic renal artery stenosis; Percutaneous transluminal angioplasty; Renovascular hypertension; Restenosis; Revascularization

Indexed keywords

ANTIHYPERTENSIVE AGENT; CREATININE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RECURRENT DISEASE; RESTENOSIS; REVASCULARIZATION; RISK FACTOR; SEX RATIO; TREATMENT FAILURE; VASCULAR PATENCY;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON; COHORT STUDIES; FEMALE; GRAFT OCCLUSION, VASCULAR; HUMANS; HYPERTENSION, RENAL; MALE; MIDDLE AGED; RENAL ARTERY; RENAL ARTERY OBSTRUCTION;

EID: 35048877876     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000108105     Document Type: Article

References (31)

1. Safian RD, Textor SC: Renal artery stenosis. N Engl J Med 2001;344:431-442.
2. Hollenberg NK: Medical therapy for renovascular hypertension: a review. Am J Hypertens 1988;1(4 Pt 2):338S-343S.
3. Cicuto KP, McLean GK, Oleaga JA, Freiman DB, Grossman RA, Ring EJ: Renal artery stenosis: anatomic classification for percutaneous transluminal angioplasty. AJR Am J Roentgenol 1981;137:599-601.
4. Isles CG, Robertson S, Hill D: Management of renovascular disease: a review of renal artery stenting in ten studies. QJM 1999;92:159-167.
5. Dorros G, Jaff M, Jain A, Dufek C, Mathiak L: Follow-up of primary Palmaz-Schatz stent placement for atherosclerotic renal artery stenosis. Am J Cardiol 1995;75:1051-1055.
6. Leertouwer TC, Gussenhoven EJ, Bosch JL, van Jaarsveld BC, van Dijk LC, Deinum J, Man In 't Veld AJ: Stent placement for renal arterial stenosis: where do we stand? A metaanalysis. Radiology. 2000;216:78-85.
7. Rundback JH, Sacks D, Kent KC, Cooper C, Jones D, Murphy T, Rosenfield K, White C, Bettmann M, Cortell S, Puschett J, Clair DG, Cole P: Guidelines for the reporting of renal artery revascularization in clinical trials. J Vasc Interv Radiol 2003;14(9 Pt 2):S477-S492.
8. van de Ven PJ, Kaatee R, Beutler JJ, Beek FJ, Woittiez AJ, Buskens E, Koomans HA, Mali WP: Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: a randomised trial. Lancet 1999;353:282-286.
9. Bakker J, Goffette PP, Henry M, Mali WP, Melki JP, Moss JG, Rabbia C, Therasse E, Thomson KR, Thurnher S, Vignali C: The Erasme study: a multicenter study on the safety and technical results of the Palmaz stent used for the treatment of atherosclerotic ostial renal artery stenosis. Cardiovasc Intervent Radiol 1999;22:468-474.
10. Blum U, Krumme B, Flügel P, Gabelmann A, Lehnert T, Buitrago-Tellez C, Schollmeyer P, Langer M: Treatment of ostial renal-artery stenoses with vascular endoprostheses after unsuccessful balloon angioplasty. N Engl J Med 1997;336:459-465.
11. Weibull H, Bergqvist D, Bergentz SE, Jonsson K, Hulthén L, Manhem P: Percutaneous transluminal renal angioplasty versus surgical reconstruction of atherosclerotic renal artery stenosis: a prospective randomized study. J Vasc Surg 1993;18:841-850.
12. Shammas NW, Kapalis MJ, Dippel EJ, Jerin MJ, Lemke JH, Patel P, Harris M: Clinical and angiographic predictors of restenosis following renal artery stenting. J Invasive Cardiol 2004;16:10-13.
13. Mali WP, van de Ven PJ, Beek FJ, Vos JA, Beutler JJ: Repeated intervention for in-stent restenosis of the renal arteries. J Vasc Interv Radiol 2002;13:1219-1224.
14. Dorros G, Jaff M, Mathiak L, Dorros II, Lowe A, Murphy K, He T: Four-year follow-up of Palmaz-Schatz stent revascularization as treatment for atherosclerotic renal artery stenosis. Circulation 1998;98:642-647.
15. Singh M, Gersh BJ, McClelland RL, Ho KK, Willerson JT, Penny WF, Holmes DR Jr: Predictive factors for ischemic target vessel revascularization in the Prevention of Restenosis with Tranilast and Its Outcomes (PRESTO) trial. J Am Coll Cardiol 2005;45:198-203.
16. Lederman RJ, Mendelsohn FO, Santos R, Phillips HR, Stack RS, Crowley JJ: Primary renal artery stenting: characteristics and outcomes after 363 procedures. Am Heart J 2001;142:314-323.
17. Takagi T, Yoshida K, Akasaka T, Kaji S, Kawamoto T, Honda Y, Yamamuro A, Hozumi T, Morioka S: Hyperinsulinemia during oral glucose tolerance test is associated with increased neointimal tissue proliferation after coronary stent implantation in nondiabetic patients: a serial intravascular ultrasound study. J Am Coll Cardiol 2000;36:731-738.
18. Nikolsky E, Kosinski E, Mishkel GJ, Kimmelstiel C, McGarry TF Jr, Mehran R, Leon MB, Russell ME, Ellis SG, Stone GW: Impact of obesity on revascularization and restenosis rates after bare-metal and drug-eluting stent implantation (from the TAXUS-IV trial). Am J Cardiol 2005;95:709-715.
19. Rana JS, Mittleman MA, Ho KK, Cutlip DE: Obesity and clinical restenosis after coronary placement. Am Heart J 2005;150:821-826.
20. Dighero TH, Wajner AJ, Puentes RA, Zepeda MF, Bellet PA, Donoso PH, Guillem VA, Aranda CW: One-year follow-up of successful coronary angioplasty in nonselected patients (in Spanish). Rev Med Chil 2006;134:1383-1392.
21. Hassani SE, Wolfram RM, Kuchulakanti PK, Xue Z, Gevorkian N, Suddath WO, Satler LF, Kent KM, Pichard AD, Weissman NJ, Waksman R: Percutaneous coronary intervention with drug-eluting stents in octogenarians: characteristics, clinical presentation and outcomes. Catheter Cardiovasc Interv 2006;68:36-43.
22. Hassani SE, Chu WW, Wolfram RM, Kuchulakanti PK, Xue Z, Gevorkian N, Suddath WO, Satler LF, Kent KM, Pichard AD, Weissman NJ, Waksman R: Clinical outcomes after percutaneous coronary intervention with drug-eluting stents in dialysis patients. J Invasive Cardiol 2006;18:273-277.
23. Haffner SM, Taegtmeyer H: Epidemic obesity and the metabolic syndrome. Circulation 2003;108:1541-1545.
24. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW: C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999;19:972-978.
25. Chan JC, Cheung JC, Stehouwer CD, Emeis JJ, Tong PC, Ko GT, Yudkin JS: The central roles of obesity-associated dyslipidaemia, endothelial activation and cytokines in the metabolic syndrome - an analysis by structural equation modelling. Int J Obes Relat Metab Disord 2002;26:994-1008.
26. Ridker PM, Hennekens CH, Buring JE, Rifai N: C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000;342:836-843.
27. Cipollone F, Marini M, Fazia M, Pini B, Iezzi A, Reale M, Paloscia L, Materazzo G, D'Annunzio E, Conti P, Chiarelli F, Cuccurullo F, Mezzetti A: Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty. Arterioscler Thromb Vasc Biol 2001;21:327-334.
28. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, Caro JF: Serum immunoreactive leptin concentrations in normal-weight and obese humans. N Engl J Med 1996;334:292-295.
29. Beltowski J: Effect of hyperleptinemia on endothelial nitric oxide production. Atherosclerosis 2005;178:403-404.
30. Beltowski J: Leptin and atherosclerosis. Atherosclerosis 2006;189:47-60.
31. Guneri S, Baris N, Aytekin D, Akdeniz B, Pekel N, Bozdemir V: The relationship between angiotensin-converting enzyme gene polymorphism, coronary artery disease, and stent restenosis: the role of angiotensin-converting enzyme inhibitors in stent restenosis in patients with diabetes mellitus. Int Heart J 2005;46:889-897.